Supply Chain Intelligence

Inhibitor Therapeutics, Inc. Supply Chain

INTI supply chain intelligence for Inhibitor Therapeutics, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

INTI ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

4Suppliers
3Customers
1Debt Items
20Related Chains

Inhibitor Therapeutics, Inc. Suppliers

TickerNameConfidenceEvidence
FRAMESHIFT-MANAGEMENT-INC FRAMESHIFT-MANAGEMENT-INC 92% Frameshift shall provide the Company with consulting services for biostatistics, regulatory, business development and strategic consulting in support of Company’s programs
JOHNS-HOPKINS-UNIVERSITY JOHNS-HOPKINS-UNIVERSITY 90% On December 12, 2023, the Company entered into an Exclusive License Agreement (the “Agreement”) with Johns Hopkins University ("JHU").
MAYNE-PHARMA MAYNE-PHARMA 85% License Agreement by and between the Company and Mayne Pharma, dated December 13, 2022
SCIQUUS-INC SCIQUUS-INC 85% Master Clinical Services Agreement, dated June 15, 2015, by and between the Company and SciQuus, Inc.

Inhibitor Therapeutics, Inc. Customers

TickerNameConfidenceEvidence
INSTITUTIONAL-INVESTOR INSTITUTIONAL-INVESTOR 92% On February 24, 2026, Inhibitor Therapeutics, Inc. (the “ Company ”) filed a Current Report on Form 8-K (the “February 24 th Form 8-K”) with the Securities and Exchange Commission (the “Commission”) …
ORANY ORANY 72% ses of the civil False Claims Act or the civil monetary penalties statute, which imposes penalties against any person who is determined to have presented or caused to be presented a claim to a federa…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from INTI graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from INTI graph: ses of the civil False Claims Act…

Inhibitor Therapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
INTI-DEBT-10306 Warrants outstanding: 53093902 90% xbrl warrant detail from xbrl 2018-12-31.

Inhibitor Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Inhibitor Therapeutics, Inc..

Inhibitor Therapeutics, Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Inhibitor Therapeutics, Inc..

Inhibitor Therapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
ORANY ORANGE 100.00 1 ['customer']
AMZE Amaze Holdings, Inc. 50.00 2
DWTX Dogwood Therapeutics, Inc. 50.00 2
CPRX Catalyst Pharmaceuticals, Inc. 50.00 2
AYTU Aytu BioPharma, Inc. 50.00 2
D Dominion Energy, Inc. 50.00 2
DARE Daré Bioscience, Inc. 50.00 2
CANF Can-Fite BioPharma Ltd. 50.00 2
DFTX Definium Therapeutics, Inc. 50.00 2
CHUC Charlie's Holdings, Inc. 50.00 2
CLNE Clean Energy Fuels Corp. 50.00 2
FENC Fennec Pharmaceuticals Inc. 50.00 2
EQR Equity Residential 50.00 2
CNOB ConnectOne Bancorp, Inc. 50.00 2
CYCN Cyclerion Therapeutics, Inc. 50.00 2
ESS Essex Property Trust, Inc. 50.00 2
ED Consolidated Edison, Inc. 50.00 2
SCNX Scienture Holdings, Inc. 50.00 2
CORT Corcept Therapeutics Incorporated 50.00 2
BLTE Belite Bio, Inc 50.00 2
View INTI supply chain intel →

Explore the full interactive supply chain map for Inhibitor Therapeutics, Inc..

Open INTI supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map